Build with KISHO Sign In Sign Up

Kisho

Eton Pharmaceuticals, Inc. — Rare Disease Pipeline | Kisho | Kisho

Eton Pharmaceuticals, Inc.

Other

3

Orphan Designations

4

FDA Approvals

19

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
Bethlem myopathy 1A	Khindivi	Orphan Designation	-
COG4-congenital disorder of glycosylation	Increlex	Orphan Designation	-
Mowat-Wilson syndrome	Galzin	Orphan Designation	-
Wilson disease	Galzin	Orphan Designation	-
adrenocortical carcinoma, hereditary	Khindivi	Orphan Designation	-
alternating hemiplegia of childhood	Khindivi	Orphan Designation	-
carbon monoxide-induced delayed encephalopathy	Galzin	Orphan Designation	-
cardiomyopathy, familial hypertrophic, 31	Khindivi	Orphan Designation	-
cerebrooculofacioskeletal syndrome 4	Increlex	Orphan Designation	-
congenital myopathy 26	Khindivi	Orphan Designation	-
glycogen storage disease VI	Increlex	Orphan Designation	-
growth hormone insensitivity syndrome	Increlex	Orphan Designation	-
inflammatory bowel disease 1	Increlex	Orphan Designation	-
multisystemic smooth muscle dysfunction syndrome	Galzin	Orphan Designation	-
natal teeth-intestinal pseudoobstruction-patent ductus syndrome	Galzin	Orphan Designation	-
pediatric hepatocellular carcinoma	Khindivi	Orphan Designation	-
pediatric ovarian dysgerminoma	Khindivi	Orphan Designation	-
pediatric-onset Graves disease	Khindivi	Orphan Designation	-
severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome	Increlex	Orphan Designation	-

← Back to Companies